SD Biosensor Inc
KRX:137310
SD Biosensor Inc
KRX:137310
Price:
9 630
KRW
7.36%
Market Closed
Market Cap:
1.2T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
SD Biosensor Inc
9630
+660 (+7.36%)
| 52 Week Range |
7 880
14 850
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
SD Biosensor Inc
Income Statement
Earnings Waterfall
SD Biosensor Inc
SD Biosensor Inc
|
Revenue
|
654.5B
KRW
|
|
Cost of Revenue
|
-373.2B
KRW
|
|
Gross Profit
|
281.3B
KRW
|
|
Operating Expenses
|
-380.6B
KRW
|
|
Operating Income
|
-99.3B
KRW
|
|
Other Expenses
|
-93.1B
KRW
|
|
Net Income
|
-192.4B
KRW
|
Income Statement
SD Biosensor Inc
SD Biosensor Inc
Currency: KRW
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Revenue |
1 686 163
N/A
|
2 843 265
+69%
|
3 426 350
+21%
|
3 417 145
0%
|
2 929 961
-14%
|
3 139 288
+7%
|
3 153 907
+0%
|
3 178 373
+1%
|
2 932 001
-8%
|
1 725 958
-41%
|
1 093 588
-37%
|
693 451
-37%
|
655 677
-5%
|
649 665
-1%
|
654 489
+1%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(828 001)
|
(1 377 596)
|
(1 608 162)
|
(1 587 537)
|
(1 336 038)
|
(1 462 247)
|
(1 503 461)
|
(1 525 880)
|
(1 539 007)
|
(1 030 199)
|
(779 919)
|
(693 749)
|
(529 674)
|
(413 014)
|
(373 188)
|
|
| Gross Profit |
858 162
N/A
|
1 465 668
+71%
|
1 818 187
+24%
|
1 829 608
+1%
|
1 593 923
-13%
|
1 677 041
+5%
|
1 650 446
-2%
|
1 652 493
+0%
|
1 392 995
-16%
|
695 759
-50%
|
313 668
-55%
|
(298)
N/A
|
126 002
N/A
|
236 651
+88%
|
281 300
+19%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(119 898)
|
(148 317)
|
(184 690)
|
(189 994)
|
(206 190)
|
(230 436)
|
(252 599)
|
(245 701)
|
(246 370)
|
(301 168)
|
(343 629)
|
(367 348)
|
(374 087)
|
(497 342)
|
(380 601)
|
|
| Selling, General & Administrative |
(106 982)
|
(132 854)
|
(163 158)
|
(165 027)
|
(181 291)
|
(198 382)
|
(212 425)
|
(198 383)
|
(185 228)
|
(208 161)
|
(228 676)
|
(226 307)
|
(217 232)
|
(228 780)
|
(203 009)
|
|
| Research & Development |
(10 388)
|
(8 099)
|
(13 193)
|
(15 934)
|
(18 964)
|
(23 379)
|
(29 393)
|
(34 759)
|
(43 850)
|
(53 111)
|
(56 685)
|
(62 952)
|
(60 858)
|
(68 928)
|
(75 528)
|
|
| Depreciation & Amortization |
(2 528)
|
(3 460)
|
(4 436)
|
(5 129)
|
(5 935)
|
(6 431)
|
(8 537)
|
(10 314)
|
(17 292)
|
(31 261)
|
(49 634)
|
(69 454)
|
(95 997)
|
(99 766)
|
(102 064)
|
|
| Other Operating Expenses |
0
|
(3 904)
|
(3 904)
|
(3 904)
|
0
|
(2 245)
|
(2 245)
|
(2 245)
|
0
|
(8 634)
|
(8 634)
|
(8 634)
|
0
|
(99 869)
|
0
|
|
| Operating Income |
738 264
N/A
|
1 317 351
+78%
|
1 633 497
+24%
|
1 639 615
+0%
|
1 387 733
-15%
|
1 446 605
+4%
|
1 397 847
-3%
|
1 406 792
+1%
|
1 146 624
-18%
|
394 592
-66%
|
(29 960)
N/A
|
(367 646)
-1 127%
|
(248 085)
+33%
|
(260 691)
-5%
|
(99 301)
+62%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(19 960)
|
1 327
|
3 521
|
47 184
|
83 792
|
90 641
|
209 200
|
356 959
|
118 370
|
68 548
|
(57 838)
|
(271 843)
|
(55 332)
|
(40 141)
|
(43 605)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(2 283)
|
0
|
0
|
0
|
(8 634)
|
0
|
0
|
0
|
(99 869)
|
0
|
(99 003)
|
|
| Gain/Loss on Disposition of Assets |
(581)
|
(1 283)
|
(1 389)
|
(1 456)
|
(1 373)
|
(787)
|
(521)
|
(1 072)
|
(1 804)
|
(1 350)
|
(1 137)
|
(1 386)
|
(1 045)
|
283
|
(15)
|
|
| Total Other Income |
(487)
|
(1 557)
|
(2 909)
|
(3 789)
|
(3 359)
|
(3 089)
|
(4 846)
|
(3 526)
|
(12 468)
|
(17 536)
|
(16 402)
|
(16 881)
|
(34 283)
|
(2 992)
|
(2 650)
|
|
| Pre-Tax Income |
717 237
N/A
|
1 315 839
+83%
|
1 632 721
+24%
|
1 681 554
+3%
|
1 464 509
-13%
|
1 533 370
+5%
|
1 601 680
+4%
|
1 759 153
+10%
|
1 242 088
-29%
|
444 254
-64%
|
(105 338)
N/A
|
(657 756)
-524%
|
(438 614)
+33%
|
(303 540)
+31%
|
(244 573)
+19%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(95 623)
|
(255 989)
|
(358 922)
|
(386 775)
|
(376 385)
|
(390 005)
|
(406 441)
|
(394 563)
|
(333 300)
|
(232 822)
|
(104 896)
|
(37 968)
|
(29 290)
|
46 890
|
52 994
|
|
| Income from Continuing Operations |
621 614
|
1 059 850
|
1 273 798
|
1 294 778
|
1 088 124
|
1 143 366
|
1 195 239
|
1 364 590
|
908 789
|
211 432
|
(210 234)
|
(695 724)
|
(467 904)
|
(256 651)
|
(191 578)
|
|
| Income to Minority Interest |
(5 978)
|
(6 082)
|
(4 262)
|
152
|
346
|
414
|
1 530
|
1 690
|
2 574
|
2 798
|
1 954
|
1 996
|
193
|
471
|
(823)
|
|
| Net Income (Common) |
615 636
N/A
|
1 053 768
+71%
|
1 269 537
+20%
|
1 294 930
+2%
|
1 088 471
-16%
|
1 143 779
+5%
|
1 196 769
+5%
|
1 366 280
+14%
|
911 362
-33%
|
214 230
-76%
|
(208 280)
N/A
|
(693 729)
-233%
|
(467 712)
+33%
|
(256 179)
+45%
|
(192 401)
+25%
|
|
| EPS (Diluted) |
5 961.35
N/A
|
10 203.88
+71%
|
12 293.23
+20%
|
12 718.41
+3%
|
11 161.38
-12%
|
11 075.47
-1%
|
11 833.13
+7%
|
13 510.4
+14%
|
8 996.76
-33%
|
2 094.14
-77%
|
-2 035.79
N/A
|
-5 967.86
-193%
|
-4 218.95
+29%
|
-2 094.09
+50%
|
-1 572.75
+25%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
